Showing results (1051-1060 of 2,231) with videos related to
Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|September 29, 2025
ELAVL1-Regulated Bone Morphogenetic Protein 2 as a Predictive Biomarker for Ultrasound Therapy Response in Oral Squamous Cell Carcinoma Bone InfiltrationJing Feng, Feng Jiang, Jin FangCancer Biotherapy & Radiopharmaceuticals|October 6, 2025
Effects of Cancer Therapies on Immunoglobulin Synthesis: A Review of Mechanisms, Clinical Implications, and Mitigation StrategiesRahaman Shaik, Huda Khan, Mohammed Ziya Salomi, et al.Cancer Biotherapy & Radiopharmaceuticals|September 10, 2025
Evaluating the Impact of Ursodeoxycholic Acid on Hepatic Clearance of [99mTc]Tc-Sestamibi: A Randomized Controlled Trial to Improve Myocardial Perfusion ImagingElinaz Hosseinzadeh, Maryam Arefnia, Mohadeseh Bayat, et al.Cancer Biotherapy & Radiopharmaceuticals|January 27, 2023
[18F]FDG PET/CT in a Case of Mycosis Fungoides Showing an Unusual Adverse Reaction to Mogamulizumab: Correlation Between Imaging and Histological FindingsLuca Filippi, Ilaria Proietti, Vincenzo Petrozza, et al.Cancer Biotherapy & Radiopharmaceuticals|February 14, 2026
Pharmacokinetics and Dosimetry of [68Ga]Ga-PSMA-11 in Chinese Participants with Progressive Metastatic Castration-Resistant Prostate Cancer: A Phase 2 StudyWei Fan, Yonghong Li, Hongcheng Shi, et al.Cancer Biotherapy & Radiopharmaceuticals|February 6, 2026
Mapping the Intersection of Traditional Chinese Medicine and Ultrasound Therapies in Tumor Microenvironment Research (2014-2024): A Knowledge Atlas StudyRuiyi Jing, Yuxi Nie, Yueling Wu, et al.Cancer Biotherapy & Radiopharmaceuticals|June 16, 2025
Danggui Buxue Decoction Combined with Borneol Improves Cyclophosphamide-Induced Myelosuppression by Inhibiting CDK2Kui Li, Ruoxia Wu, Ting Zhou, et al.Cancer Biotherapy & Radiopharmaceuticals|June 12, 2025
Recent Breakthroughs in Exosome-Based Drug Delivery: A Comprehensive Review for Cancer TherapyDhwani Shah, Shweta Gandhi, Shreeraj Shah, et al.Cancer Biotherapy & Radiopharmaceuticals|April 22, 2025
Anlotinib as a Tailored Treatment for Extensive-Stage Small Cell Lung Cancer with Stable Disease after Two Cycles of First Chemotherapy Plus Immunotherapy: A Retrospective StudyYonghong Li, Xi Lin, Yi Peng, et al.Cancer Biotherapy & Radiopharmaceuticals|April 21, 2025
Small Animal Positron Emission Tomography Imaging of a Triple-Negative Breast Cancer Model Using the 68Ga-Labeled pH (Low) Insertion Peptide-Like Peptide YJL-11Mingming Yu, Fengyu Wu, Yanqin Sun, et al.Pageof 224